Featured Events:

ChinaBio® Partnering Forum 2021
May 10–14, 2021
ChinaBio® Partnering Forum, in its new hybrid delivery, enables you to identify, meet and network with leaders across the life science value chain to accelerate your cross-border partnerships and expand your reach into the China market.


Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.

Recent
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

Click a link below to view the mailing archive as if it had been sent to you.

2021-01-24 01:30Week in Review: Suzhou's Adagene to Stage $125 Million IPO on NASDAQ
2021-01-23 01:30Sinovac to Expand Production of COVID-19 Vaccine to 2 Billion Doses
2021-01-22 01:30Adagene of Suzhou Files for $125 Million US IPO and more...
2021-01-21 01:30Immunotech of Beijing In-licenses Immunotherapy from T-Cure and more...
2021-01-20 01:30Sinovent Completes Pre-IPO Financing of at least $30 Million and more...
2021-01-19 01:30EdiGene Approved to Start China Trial of Gene-Edited Stem Cell Therapy and more...
2021-01-17 01:30Week in Review: BeiGene Signs $2.2 Billion Deal with Novartis for PD-1
2021-01-16 01:30EQRx Raises $500 Million to Develop China-Sourced Drugs for US Market and more...
2021-01-15 01:30ChinaBio® Report: 2020 China Life Science Investment Hits New Records and more...
2021-01-14 01:30Gracell to Start China Trial of Donor-derived CAR-T Therapy for B-ALL
2021-01-13 01:30BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal and more...
2021-01-12 01:30ChinaBio at JP Morgan: China Biopharma Books Strong 2020, Despite Pandemic and more...
2021-01-10 01:30Week in Review: China Biopharma Starts 2021 with Over $1 Billion in Deals and IPOs
2021-01-09 01:30Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies and more...
2021-01-08 01:30Zai Lab Acquires China Rights to Novel Autoimmune Drug in $175 Million Deal and more...
2021-01-07 01:30Keya Medical Completes $46 Million Round for AI-based Scanning Software and more...
2021-01-06 01:30Terns Completes $87 Million Financing to Advance Three NASH Candidates and more...
2021-01-05 01:30Shanghai Pharma to Build $1.8 Billion Novel Drug Facility in Zhangjiang Park and more...
2021-01-03 01:30Week in Review: DXY Raises $500 Million for Online Consumer Healthcare Site
2021-01-01 01:30ImmVira Completes C Round for Oncolytic Virus and Vector Candidates and more...

Please enter all required fields Click to hide
Correct invalid entries Click to hide
 

Subscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

Greg B. Scott
Executive Editor
ChinaBio® Today


ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC